Skip to main content
. 2009 Oct 1;395(1):1–9. doi: 10.1016/j.virol.2009.09.007

Fig. 6.

Fig. 6

SNAP treatment causes a difference in observed levels of replicase polyprotein cleavage products. Lysates from either uninfected or SARS-CoV infected Vero E6 cells which had either been treated with SNAP, NAP or mock-treated harvested 24 h post-infection were subjected to Western blot analysis using a monoclonal antibody targeting the nsp8 protein.